Comparing cell imaging to standard frozen section for breast surgery margins
Part of Cancer, Skin clinical trials.
This trial compares a new cell-imaging method with standard frozen pathology to check if all cancer has been removed during breast-conserving surgery. It aims to see which method is more accurate at analyzing the surgical margin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a single breast tumor that hasn't spread to other parts of the body.
- The cancer has not grown into the skin, chest muscle, or nipple area.
- You are willing to have breast-conserving surgery (removing just the tumor).
- You are healthy enough for general anesthesia and surgery.
- You can provide tissue samples for testing during surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
This trial tests a new high-resolution PET/CT scanner used during breast-conserving surgery to check if all cancer has been removed. It aims to reduce the need for repeat surgeries by giving surgeons real-time feedback on tumor margins.
This trial compares a newer, less invasive endoscopic surgery (using a single small cut) to the traditional open surgery for removing breast cancer while keeping the breast. It's for women with early-stage breast cancer who want a breast-conserving option.
This trial tests a new technology that helps doctors examine cells during surgery for early-stage breast cancer. It may help make the sentinel lymph node biopsy more accurate.
This study tests a scanner (Histolog®) that checks the edges of removed breast tissue during surgery to make sure all cancer is removed. The goal is to reduce the need for a second surgery.
This study compares two ways surgeons take “margin” samples (tissue from the edge of the tumor area) during breast-conserving surgery for early breast cancer. It uses a guidance device to help collect these samples and aims to see which approach better supports safe, effective treatment.
Hear when a new Breast-conserving Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.